Skip to main content
About
Company Overview
Corporate Policies
Governance Policies
Team
Partners
Careers
Research
Clinical Trials
Publications
Pipeline
Investors
Newsroom
Contact
Facebook
Twitter
Linkedin
MENU
Close Menu
Home
About
Company Overview
Team
Partners
Careers
Patient Resource
Pipeline
Investors
Newsroom
Contact
Home
Investors
Overview
Events and Presentations
Stock Info
Financials
Governance
Board of Directors
Executive Management
Committee Composition
Resources
Shareholder Info
FAQs
Email Alerts
Newsroom
Press Releases
Videos
Videos
Home
Investors
Overview
Events and Presentations
Stock Info
Financials
Governance
Board of Directors
Executive Management
Committee Composition
Resources
Shareholder Info
FAQs
Email Alerts
Newsroom
Press Releases
Videos
Tetra Bio-Pharma – Cannabis in Pain Evidence of Its Value as an Alternative
December 11, 2020
Tetra Bio-Pharma – AlphaBronze Town Hall
October 28, 2020
Tetra Bio-Pharma – AlphaBronze Town Hall
October 8, 2020
Tetra Bio-Pharma Invites You To Guy’s Virtual Outreach To Investors
April 9, 2020
CAUMZ Product Development
March 27, 2020
Corona Virus
April 6, 2020
Dr. Guy Chamberland shares insights on CBD in food products and regulatory compliance
August 9, 2019
Can cannabinoid-derived drugs help address the opioid crisis? Hear from Dr. Guy Chamberland on how Tetra Bio-Pharma is leading the way.
July 18, 2019
Steeve Neron - Video interview TVA - 1er mars 2019
June 3, 2019 (In French)
What is ahead for Tetra Bio-Pharma in 2019
January 3, 2019
Tetra CEO and CSO Dr. Guy Chamberland summarizes the corporations accomplishments during the last two quarters
December 31, 2018
Tetra Bio-Pharma CEO, CSO Dr. Guy Chamberland comments on the risks of recreational cannabis on your health
December 28, 2018
2018 A Year of Growth and Innovation
December 20, 2018
Tetra Bio Pharma ready to lead in cannabinoid drug development
December 6, 2018